Upgrade to SI Premium - Free Trial

Vertex Pharma (VRTX): Cutting PT But Fundamentals Continue To Look Good - Jefferies

October 26, 2016 8:39 AM
Jefferies analyst, Brian Abrahams, reiterated his Buy rating on shares of Vertex (NASDAQ: VRTX) but cut his price target to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles